Pramipexole Synthesis via Parameter Control and Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing pramipexole lack an economical and industrially acceptable process that achieves high yields while preserving optical purity and avoiding side product formation.
Innovation Solution
A novel process involving the reaction of 4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine with nitro or halogen substituted aryl sulfonyl chloride, followed by conversion with a selective reagent to form pramipexole, which can be further converted into its pharmaceutically acceptable dihydrochloride salt, using specific organic and inorganic bases and solvents to maintain high optical purity and prevent racemization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthesis methods are used, then pramipexole can be produced, but optical purity is lost due to racemization
Solution Approach 1:
The patent employs parameter changes by carefully controlling reaction conditions including temperature ranges (-78°C to room temperature), solvent selection (ether, ester, nitrile, or their mixtures), and reagent addition rates to prevent racemization and maintain optical purity throughout the synthesis process
Solution Approach 2:
The patent uses specific intermediates in the synthesis pathway, particularly the formation of diastereoisomeric salts as intermediaries that facilitate selective crystallization and separation of enantiomers, thereby preserving optical purity through controlled intermediate states
2Ease of manufacture
If synthesis process is simplified, then production cost decreases, but yield and purity may be compromised
Solution Approach 1:
The patent divides the synthesis into distinct sequential steps: formation of sulfonamide intermediate, alkylation to introduce propyl group, and final deprotection to yield pramipexole. This segmentation allows optimization of each step independently while maintaining overall efficiency and purity
Solution Approach 2:
The patent implements continuous useful action by designing a synthesis pathway where each reaction step directly produces the necessary intermediate for the next step without requiring isolation or purification between steps, thereby maintaining high yield and purity while reducing production complexity
3Productivity
If reaction conditions are optimized for high conversion, then productivity increases, but side products may form
Solution Approach 1:
The patent applies local quality by using selective reagents and conditions for each specific transformation: mild base catalysis for sulfonamide formation, controlled alkylation conditions for propyl group introduction, and selective deprotection conditions. This localized optimization ensures high conversion at each step while minimizing side reactions
Solution Approach 2:
The patent employs preliminary anti-action by adding racemization prevention measures before they become problematic: using controlled temperature profiles, selecting appropriate solvents, and implementing protective group strategies that prevent unwanted reactions before they can occur, thereby maintaining high conversion without side product formation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high conversion rates of intermediates, preserves optical purity, and avoids the formation of undesired side products, resulting in a cost-effective and industrially viable synthesis of pramipexole with high optical purity.
Implementation Method 1
A reaction of a compound I with a compound II is carried out in the presence of an inorganic or organic base
Implementation Method 2
a conversion of intermediate of formula V with a selective reagent for a cleaving off of the sulfonyl protection into pramipexole
Implementation Method 3
Pramipexole, preferably its dihidrochloride monohydrate, is a compound used for a treatment of Parkinson's disease
Data Source
AI summary
The present invention relates to a novel process for synthesis of pramipexole, shown in the synthesis scheme. Formulae (I), (II), (III), (IV), (V) and (VI).